Researchers Identify Virus and Two Types of Bacteria as Major Causes of Alzheimer’s
Neuroscience News March 9, 2016
‘A worldwide team of senior scientists and clinicians have come together to produce an editorial which indicates that certain microbes – a specific virus and two specific types of bacteria – are major causes of Alzheimer’s Disease. Their paper, which has been published online in the highly regarded peer-reviewed journal, Journal of Alzheimer’s Disease, stresses the urgent need for further research – and more importantly, for clinical trials of anti-microbial and related agents to treat the disease.‘
The full article can be read – http://neurosciencenews.com/microbes-alzheimers-neurology-3826/
The original editorial can be found on ISO press
Microbes and Alzheimer’s Disease
http://content.iospress.com/articles/journal-of-alzheimers-disease/jad160152
‘We are researchers and clinicians working on Alzheimer’s disease (AD) or related topics, and we write to express our concern that one particular aspect of the disease has been neglected, even though treatment based on it might slow or arrest AD progression. We refer to the many studies, mainly on humans, implicating specific microbes in the elderly brain, notably herpes simplex virus type 1 (HSV1), Chlamydia pneumoniae, and several types of spirochaete, in the etiology of AD [1–4]. Fungal infection of AD brain [5, 6] has also been described, as well as abnormal microbiota in AD patient blood [7]. The first observations of HSV1 in AD brain were reported almost three decades ago [8]. The ever-increasing number of these studies (now about 100 on HSV1 alone) warrants re-evaluation of the infection and AD concept.
One of the authors is Prof Judith Miklossy who has published a number of papers on Borrelia and other spirochetes associated with Alzheimer’s disease
http://content.iospress.com/search?q=author%3A%28%22Miklossy,%20Judith%22%29
In the summary ‘We propose that further research on the role of infectious agents in AD causation, including prospective trials of antimicrobial therapy, is now justified.’
This editorial is being widely quoted in the media.
